Table 1.
The Baseline Characteristics of Patients with COVID-19
| Group A (n = 255) | Group B (n = 259) | P value | |
|---|---|---|---|
| Age (years) | 36.00 (29.00, 45.00) | 34.00 (28.00, 45.00) | 0.337 |
| Sex [n (%)] | 0.607 | ||
| Male | 60(23.53) | 66(25.48) | |
| Female | 195(76.47) | 193(74.52) | |
| Marital status [n (%)] | 0.257 | ||
| Unmarried | 45(17.6) | 56(21.6) | |
| Married | 210(82.4) | 203(78.4) | |
| Region [n (%)] | 0.002 | ||
| North | 20(7.8) | 5(1.9) | |
| South | 235(92.2) | 254(98.1) | |
| Residence [n (%)] | 0.979 | ||
| Rural | 41(16.1) | 40(15.4) | |
| Township | 67(26.3) | 68(26.3) | |
| Urban | 147(57.6) | 151(58.3) | |
| Medical staff [n (%)] | 153(60.0) | 206(79.5) | 0.000 |
| Smoking [n (%)] | 0.552 | ||
| Never smoking | 226(88.6) | 231(89.2) | |
| Smoking | 25(9.8) | 21(8.1) | |
| Quit smoking | 4(1.6) | 7(2.7) | |
| Drinking [n (%)] | 0.294 | ||
| Never drinking | 207(81.2) | 210(81.1) | |
| Drinking | 45(17.6) | 41(15.8) | |
| Quit drinking | 3(1.2) | 8(3.1) | |
| Physical Exercise [n (%)] | 99(38.8) | 77(29.7) | 0.030 |
| Sleeping Hours [n (%)] | 0.001 | ||
| < 6 h | 50(19.6) | 82(31.7)a | |
| 6–7 h | 108(42.4) | 110(42.5) | |
| ≥7 h | 97(38.0) | 67(25.9)a | |
| Bedtime [n (%)] | 0.029 | ||
| 10 pm and before 10 pm | 65(25.5) | 40(15.4)a | |
| 11 pm | 91(35.7) | 112(43.2) | |
| 12 pm | 77(30.2) | 88(34.0) | |
| after 12 pm | 22(8.6) | 19(7.3) | |
| Disease History [n (%)] | 46(18.0) | 54(20.8) | 0.421 |
| Hypertension [n (%)] | 20 (7.8) | 21 (8.1) | 0.912 |
| Diabetes [n (%)] | 9 (3.5) | 3 (1.2) | 0.075 |
| Hyperlipidemia [n (%)] | 20 (7.8) | 23 (8.9) | 0.671 |
| Chronic Respiratory Disease [n (%)] | 3 (1.2) | 3 (1.2) | 0.985 |
| Chronic Kidney Disease [n (%)] | 3 (1.2) | 1 (0.4) | 0.308 |
| Rheumatic Disease [n (%)] | 5 (2.0) | 3 (1.2) | 0.462 |
| Cancers [n (%)] | 3 (1.2) | 4 (1.5) | 0.719 |
| Vaccination [n (%)] | 0.944 | ||
| no | 4(1.6) | 4(1.5) | |
| one | 3(1.2) | 2(0.8) | |
| two | 21(8.2) | 24(9.3) | |
| three | 212(83.1) | 217(83.8) | |
| four | 15(5.9) | 12(4.6) | |
| Treatment [n (%)] | 0.146 | ||
| None | 42 (16.5) | 33 (12.7) | |
| Self-medication | 200 (78.4) | 203 (78.4) | |
| Medical prescription | 13 (5.1) | 23 (8.9) |
Notes:aStatistical comparison between group A and group B
Abbreviations: group A, the time for negative conversion < 11 days; group B, the time for negative conversion ≥11 days; COVID-19, coronavirus disease 2019